My point is that there is no evidence that either 2-73 or Bryostatin is superior. They aren't being tested in similar populations so a 1 on 1 comparison is not possible.
I prefer Anavex because they are having trials in three different diseases and the trials are run according to 21st century precision medicine protocol so they will be quicker and they will yield additional knowledge.
Market Data 
Markets 
AI
